Protocol and statistical analysis plan for the Mode of Ventilation During Critical IllnEss (MODE) trial

Author:

Seitz Kevin P.,Lloyd Bradley D.,Wang Li,Shotwell Matthew S.,Qian Edward T.,Richardson Roger K.,Rooks Jeffery C.,Hennings-Williams Vanessa,Sandoval Claire E.,Richardson Whitney D.,Morgan Tracy,Thompson Amber N.,Hastings Pamela G.,Ring Terry P.,Stollings Joanna L.,Talbot Erica M.,Krasinski David J.,Decoursey Bailey,Gibbs Kevin W.,Self Wesley H.,Mixon Amanda S.,Rice Todd W.,Semler Matthew W.,Casey Jonathan D.

Abstract

ABSTRACTIntroduction:For every critically ill adult receiving invasive mechanical ventilation, clinicians must select a mode of ventilation. The mode of ventilation determines whether the ventilator directly controls the tidal volume or the inspiratory pressure. Newer hybrid modes allow clinicians to set a target tidal volume, for which the ventilator controls and adjusts the inspiratory pressure. A strategy of low tidal volumes and low plateau pressure improves outcomes, but the optimal mode to achieve these targets is not known.Methods and analysis:The Mode of Ventilation During Critical Illness (MODE) trial is a cluster-randomized, multiple-crossover pilot trial being conducted in the medical intensive care unit (ICU) at an academic center. The MODE trial compares the use of volume control, pressure control, and adaptive pressure control. The study ICU is assigned to a single ventilator mode (volume control versus pressure control versus adaptive pressure control) for continuous mandatory ventilation during each 1-month study block. The assigned mode switches every month in a randomly generated sequence. The primary outcome is ventilator-free days (VFDs) to study day 28, defined as the number of days alive and free of invasive mechanical ventilation from the final receipt of mechanical ventilation to 28 days after enrollment. Enrollment began November 1, 2022 and will end on July 31, 2023.Ethics and dissemination:The trial was approved by the Vanderbilt University Medical Center institutional review board (IRB# 220446). Results of this study will be submitted to a peer-reviewed journal and presented at scientific conferences.Trial registration number:The trial was registered withclinicaltrials.govon October 3, 2022, prior to initiation of patient enrollment on November 1, 2022 (ClinicalTrials.govidentifier:NCT05563779)

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3